Clinical Outcomes of ACL Reconstruction Augmented by an Injectable Osteoconductive/Osteoinductive Compound
Status:
Completed
Trial end date:
2020-02-20
Target enrollment:
Participant gender:
Summary
The goal of this study is to determine whether the use of injectable
osteoinductive/osteoconductive compounds (OOC) during Anterior Cruciate Ligament (ACL)
reconstructive surgery, combined with an accelerated rehabilitation protocol (ARP) provides
clinical outcomes superior to those attained via traditional ACL reconstruction and delayed
rehabilitation protocols.